Setipiprant Powder is a new research drug used to treat asthma and scalp hair loss. It was originally developed by Actelion as a selective, oral antagonist of prostaglandin D2 receptor 2 (DP2). But despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients, it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.
However, because of its prominence in the field of hair loss treatment, Setipiprant is widely used to treat male pattern baldness.
English name: Setipiprant Powder
Appearance: White fine powder
Molecular Formula: C24H19FN2O3
Molecular Weight: 402.425
Purity: Over 99%
Test Method: HPLC